(AKTX) Akari Therapeutics - Performance -47.1% in 12m
Compare AKTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-86.10%
#161 in Group
Rel. Strength 12m
12.14%
#6877 in Universe
Total Return 12m
-47.06%
#146 in Group
Total Return 5y
-94.90%
#163 in Group
12m Total Return: AKTX (-47.1%) vs XLV (0.9%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group (based on Performance, Valuations and Relative Strength)
| Symbol | 1m | 12m | 5y | P/E | P/B | Growth Rating |
|---|---|---|---|---|---|---|
| CPH TO Cipher Pharmaceuticals |
-12.0% | 59.2% | 2,125% | 12.84 | 2.36 | 90.59 |
| PBH NYSE Prestige Brand Holdings |
-2.69% | 13.1% | 176% | 20.90 | 2.41 | 88.84 |
| NVS NYSE Novartis |
7.17% | 15.1% | 93.0% | 19.67 | 5.18 | 67.99 |
| NOVN SW Novartis |
4.64% | 15.0% | 76.8% | 19.33 | 5.01 | 64.74 |
| RDY NYSE Dr. Reddy’s Laboratories |
-6.76% | -10.8% | 108% | 17.18 | 2.90 | 53.55 |
Performance Duell AKTX vs XLV
| Total Return (including Dividends) | AKTX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 0.00% | 0.09% | -7.69% |
| 3 Months | 9.31% | 4.51% | -6.94% |
| 12 Months | -47.06% | 0.88% | 10.70% |
| 5 Years | -94.90% | 92.03% | 153.10% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #63 | -0.09% | 8.33% |
| 3 Month | #52 | 4.60% | 17.5% |
| 12 Month | #146 | -47.5% | -52.2% |
| 5 Years | #166 | -97.4% | -98.0% |
| Trend Score (consistency of price movement) | AKTX | XLV | S&P 500 |
| 1 Month | -52.8% | 8.1% | -96% |
| 3 Months | -34.6% | 81.6% | -21% |
| 12 Months | -42.6% | 23.2% | 91% |
| 5 Years | -93.8% | 90.5% | 84.5% |
FAQs
Does AKTX Akari Therapeutics outperforms the market?
No,
over the last 12 months AKTX made -47.06%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.88%.
Over the last 3 months AKTX made 9.31%, while XLV made 4.51%.
Over the last 3 months AKTX made 9.31%, while XLV made 4.51%.
Performance Comparison AKTX vs Indeces and Sectors
AKTX vs. Indices AKTX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 19.0% | 7.69% | -67.6% | -57.8% |
| US NASDAQ 100 | QQQ | 19.2% | 10.9% | -68.6% | -56.9% |
| US Dow Jones Industrial 30 | DIA | 19.8% | 6.69% | -67.4% | -55.3% |
| German DAX 40 | DAX | 16.8% | -2.20% | -90.3% | -74.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 13.5% | -2.69% | -92.1% | -62.4% |
| Hongkong Hang Seng | HSI | 17.6% | -6.89% | -82.4% | -61.6% |
| India NIFTY 50 | INDA | 17.1% | 1.37% | -51.7% | -44.2% |
| Brasil Bovespa | EWZ | 12.7% | 2.01% | -57.1% | -33.3% |
AKTX vs. Sectors AKTX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 20.5% | 8.29% | -77.6% | -69.0% |
| Consumer Discretionary | XLY | 21.1% | 13.4% | -69.7% | -57.3% |
| Consumer Staples | XLP | 20.8% | 1.36% | -62.6% | -55.2% |
| Energy | XLE | 14.1% | 0.34% | -72.4% | -48.7% |
| Financial | XLF | 18.0% | 6.33% | -75.4% | -67.8% |
| Health Care | XLV | 19.7% | -0.09% | -59.9% | -47.9% |
| Industrial | XLI | 19.1% | 4.67% | -67.7% | -56.1% |
| Materials | XLB | 18.9% | 4.31% | -59.8% | -43.5% |
| Real Estate | XLRE | 19.2% | 1.45% | -60.0% | -56.9% |
| Technology | XLK | 18.9% | 10.9% | -64.7% | -50.2% |
| Utilities | XLU | 14.7% | 0.29% | -68.1% | -75.5% |
| Aerospace & Defense | XAR | 16.3% | 4.14% | -73.5% | -65.6% |
| Biotech | XBI | 17.0% | 4.68% | -53.0% | -39.4% |
| Homebuilder | XHB | 21.1% | 8.61% | -48.1% | -40.6% |
| Retail | XRT | 22.6% | 14.9% | -57.0% | -38.2% |